指南与共识神经肿瘤

美国神经外科医师协会/神经外科医师大会肿瘤分会指南:评估其对脑肿瘤临床实践的影响

American Association of Neurological Surgeons/Congress of the Neurological Surgeons Section on Tumors Guidelines: Assessing Their Impact on Brain Tumor Clinical Practice.
指南 / 共识 · Neurosurgery · 2024-07-19

本文回顾美国神经外科医师协会/神经外科医师大会肿瘤分会过去十年制定的六类脑肿瘤指南,利用Google Scholar、PubMed、Altmetric及网站和CNS+应用访问数据评估其被引用、专利、政策与信息传播影响。转移性肿瘤指南(2019)PubMed年引用率最高,为每年26.1次,网页访问量达29100次页面浏览(2019年1月1日至2023年9月30日)。

要点

  • 转移性肿瘤指南(2019)PubMed年引用率最高,为每年26.1次
  • 前庭神经鞘瘤指南(2018)在Google Scholar引用率领先
  • 低级别胶质瘤指南在新闻、专利或政策出版物方面领先,为每年1.5次

核心结论

  • 美国神经外科医师协会/神经外科医师大会肿瘤分会指南的影响超出同行评议出版物引用,还包括专利、在线参与和向公众的信息传播。

研究设计与样本

  • 回顾肿瘤分会过去十年制定的六类肿瘤指南:低级别胶质瘤、新诊断胶质母细胞瘤、进展性胶质母细胞瘤、转移性脑肿瘤、前庭神经鞘瘤和垂体腺瘤。
  • 引用数据来自Google Scholar和PubMed,在线统计如社交媒体触达及政策、新闻、专利特征来自Altmetric,在线参与通过网站和CNS+移动应用访问评估,数据按发表后时间归一化。

主要发现

  • 转移性肿瘤指南(2019)PubMed年引用率最高,为每年26.1次,网页访问量最高(2019年1月1日至2023年9月30日共29100次页面浏览)。
  • 转移性肿瘤指南在X上触达最大(每年19.7次提及),并有神经肿瘤学会和美国临床肿瘤学会两个合作学会关于抗癫痫预防和类固醇使用的背书出版物。
  • Google Scholar引用率由前庭神经鞘瘤指南(2018)领先。
  • 非功能性垂体腺瘤指南在Mendeley阅读量领先。
  • 新闻、专利或政策出版物由低级别胶质瘤指南领先,为每年1.5次。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical guidelines direct healthcare professionals toward evidence-based practices. Evaluating guideline impact can elucidate information penetration, relevance, effectiveness, and alignment with evolving medical knowledge and technological advancements. As the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors marks its 40th anniversary in 2024, this article reflects on the tumor guidelines established by the Section over the past decade and explores their impact on other publications, patents, and information dissemination. Six tumor guideline categories were reviewed: low-grade glioma, newly diagnosed glioblastoma, progressive glioblastoma, metastatic brain tumors, vestibular schwannoma, and pituitary adenomas. Citation data were collected from Google Scholar and PubMed. Further online statistics, such as social media reach, and features in policy, news, and patents were sourced from Altmetric. Online engagement was assessed through website and CNS+ mobile application visits. Data were normalized to time since publication. Metastatic Tumor guidelines (2019) had the highest PubMed citation rate at 26.1 per year and webpage visits (29 100 page views 1/1/2019-9/30/2023). Notably, this guideline had two endorsement publications by partner societies, the Society of Neuro-Oncology and American Society of Clinical Oncology, concerning antiepileptic prophylaxis and steroid use, and the greatest reach on X (19.7 mentions/y). Citation rates on Google Scholar were led by Vestibular Schwannoma (2018). Non-Functioning Pituitary Adenoma led Mendeley reads. News, patent, or policy publications were led by low-grade glioma at 1.5/year. Our study shows that the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors guidelines go beyond citations in peer-reviewed publications to include patents, online engagement, and information dissemination to the public.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Robertson FC, Nahed BV, Barkhoudarian G, et al. American Association of Neurological Surgeons/Congress of the Neurological Surgeons Section on Tumors Guidelines: Assessing Their Impact on Brain Tumor Clinical Practice. Neurosurgery. 2024. PMID: 39028201. doi:10.1227/neu.0000000000003125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。